Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
Accumulating evidence has implicated members of the procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) gene family, PLOD1, PLOD2, and PLOD3, in cancer progression and metastasis. However, their expression, prognostic value, and mechanisms underlying their roles in lung adenocarcinoma (LUAD) hav...
Main Authors: | Yiming Meng, Jing Sun, Guirong Zhang, Tao Yu, Haozhe Piao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.770729/full |
Similar Items
-
Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer
by: Chen R, et al.
Published: (2023-02-01) -
Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
by: Zhang J, et al.
Published: (2022-03-01) -
Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
by: Bo Yang, et al.
Published: (2020-09-01) -
PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma
by: Siming Gong, et al.
Published: (2022-04-01) -
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
by: Haining Li, et al.
Published: (2022-03-01)